Horizon to distribute Possis Medical's dialysis graft:
This article was originally published in Clinica
Horizon Medical Products is to distribute Minneapolis-based Possis Medical's Perma-Seal dialysis access graft under an exclusive, worldwide agreement. The deal, which is subject to minimum sales requirements, is for three years initially and will be extended for a further two years if certain sales requirements are met. Manchester, Georgia-based Horizon says the product, the first and only of its type to be approved in the US, represents the "most significant technological development in the vascular graft market in a number of years".
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.